CHS Pharma Inc. on Feb. 2013 acquired its Intellectual Property Portfolio from Florida Atlantic University and Hospital for Special Surgery. The IP portfolio is considered a platform technology and currently consists of 4 issued patents, 2 allowed, and 8 applications pending. The mentioned portfolio covers drug candidates for treatments of Actinic Keratosis (Basal and Squamous cell Carcinomas in EU patent), Dry Macular Degeneration, Myocardial Infarction, and Ischemic Stroke. CHS's corporate development strategy is to develop the drug candidates up to Phase II clinical studies and at that point in time either form a strategic partnership or license the technology to other pharmaceutical companies.
Looking for a particular CHS Pharma Inc. employee's phone or email?
CHS Pharma Inc. Questions
The CHS Pharma Inc. annual revenue was $811000 in 2026.
David Rubin is the Director of Investor Relations of CHS Pharma Inc..
3 people are employed at CHS Pharma Inc..
CHS Pharma Inc. is based in Jupiter, Florida.
The NAICS codes for CHS Pharma Inc. are [3254, 32541, 32, 325].
The SIC codes for CHS Pharma Inc. are [283, 28].
Top CHS Pharma Inc. Employees
-
15+
-
Stephen Chakoff
Director at CHS Pharma Inc.
Miami, FL, US35+
Related Companies
